332
Views
59
CrossRef citations to date
0
Altmetric
Articles

Occurrence of systemic lupus erythematosus in a Danish community: an 8‐year prospective study

, , &
Pages 128-132 | Accepted 19 Aug 2008, Published online: 12 Jul 2009

References

  • Hochberg M. C. Systemic lupus erythematosus. Rheum Dis Clin North Am 1990; 16: 617–39
  • Michet C. J., Jr, McKenna C. H., Elveback L. R., Kaslow R. A., Kurland L. T. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985; 60: 105–13
  • Hochberg M. C., Perlmutter D. L., Medsger T. A., Steen V., Weisman M. H., White B., et al. Prevalence of self‐reported physician‐diagnosed systemic lupus erythematosus in the USA. Lupus 1995; 4: 454–6
  • Jonsson H., Nived O., Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989; 68: 141–50
  • Petri M. The effect of race on incidence and clinical course in systemic lupus erythematosus: The Hopkins Lupus Cohort. J Am Med Women's Assoc 1998; 53: 9–12
  • Voss A., Green A., Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county‐based cohort. Scand J Rheumatol 1998; 27: 98–105
  • Staahl‐Hallengren C., Jonsen A., Nived O., Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000; 27: 685–91
  • Nossent H. C. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 2001; 28: 539–46
  • Alamanos Y., Voulgari P. V., Siozos C., Katsimpri P., Tsintzos S., Dimou G., et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982–2001. J Rheumatol 2003; 30: 731–5
  • Chakravarty E. F., Bush T. M., Manzi S., Clarke A. E., Ward M. M. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007; 56: 2092–4
  • Statistics Denmark www.dst.dk/homeuk.aspx
  • Fries J. F., Holman H. R. Systemic lupus erythematosus: a clinical analysis. Major Probl Intern Med 1975; 6: v–199
  • Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
  • Hook E. B., Regal R. R. Capture–recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995; 17: 243–64
  • Green A., Stovring H., Andersen M., Beck‐Nielsen H. The epidemic of type 2 diabetes is a statistical artefact. Diabetologia 2005; 48: 1456–8
  • Trager J., Ward M. M. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001; 13: 345–51
  • From the Centers for Disease Control and Prevention. Trends in deaths from systemic lupus erythematosus – United States, 1979–1998. J Am Med Assoc 2002; 287: 2649–50
  • Abu‐Shakra M., Gladman D. D., Urowitz M. B. Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev 2004; 3: 418–20
  • Cervera R., Khamashta M. A., Font J., Sebastiani G. D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a 5‐year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999; 78: 167–75
  • Chun B. C., Bae S. C. Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea. Lupus 2005; 14: 635–8
  • Moss K. E., Ioannou Y., Sultan S. M., Haq I., Isenberg D. A. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002; 61: 409–13
  • Greer J. M., Panush R. S. Incomplete lupus erythematosus. Arch Intern Med 1989; 149: 2473–6
  • Swaak A. J., van den Brink H. G., Smeenk R. J., Manger K., Kalden J. R., Tosi S., et al. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation. Lupus 2001; 10: 51–8
  • Vila L. M., Mayor A. M., Valentin A. H., Garcia‐Soberal M., Vila S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 2000; 9: 110–15
  • Ganczarczyk L., Urowitz M. B., Gladman D. D. ‘Latent lupus’. J Rheumatol 1989; 16: 475–8
  • Staahl‐Hallengren H. C., Nived O., Sturfelt G. Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus 2004; 13: 85–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.